Edelweiss Alternatives fee-paying AUM rises 28% to $512.2 crore
Key highlights
- Edelweiss Alternatives' fee-paying AUM reached $512.2 crore in Q2FY27, up 28% year on year.
- Edelweiss Alternatives reported Q2FY27 PAT of $9 crore, up 27% from $7 crore in Q2FY26.
- Edelweiss Alternatives raised more than $208 crore across named strategies and InvITs in H1FY27.
- Edelweiss Alternatives reported Q2FY27 deployment of $14.5 crore and realisation of $38.8 crore.
powered by IRIS

Edelweiss Alternatives reported fee-paying assets under management (AUM) of $512.2 crore in Q2FY27, 28% above Q2FY26, and profit after tax (PAT) of $9 crore, up 27%, as annualized return on equity (RoE) reached 29% at September. The presentation also records more than $208 crore raised during H1FY27.
Know Edelweiss Financial Services inside out
Results, valuation, peers and who's buying, in one view.
How fast did Edelweiss Alternatives' fee-paying AUM grow?
Edelweiss Alternatives increased fee-paying AUM by $110.5 crore, or 28% year on year, from $401.7 crore in Q2FY26 to $512.2 crore in Q2FY27. The presentation marks both AUM balances as being as of September, making this a comparison of point-in-time balances rather than average assets managed during each quarter.
Equity rose by $2 crore to $12.7 crore at September 2026 from $10.7 crore a year earlier. The presentation places this September equity comparison alongside quarterly income, operating expense and PAT figures, but it does not provide a strategy-level split of the $512.2 crore fee-paying AUM.
The AUM increase was reported alongside fundraising across several products in H1FY27. Edelweiss Alternatives raised more than $83 crore across Special Situations, Infra Yield and Private Equity strategies, and more than $125 crore through infrastructure investment trusts, or InvITs. The source does not state how much of this capital had become fee-paying AUM by September 2026.
What fundraising and activity did Edelweiss Alternatives report?
Edelweiss Alternatives disclosed fundraising of more than $208 crore across its named strategies and InvITs in H1FY27. This is a minimum total because the source describes both the more than $83 crore raised in Special Situations, Infra Yield and Private Equity and the more than $125 crore raised in InvITs as amounts exceeding those thresholds.
For Q2FY27, Edelweiss Alternatives reported deployment of $14.5 crore and realisation of $38.8 crore. Realisation exceeded deployment by $24.3 crore on the disclosed quarterly figures, although the presentation does not identify the investments, exits or funds behind either amount.
Edelweiss Alternatives also launched IYP III, its third-vintage infrastructure yield fund, during the reported period. The source identifies the new fund but does not disclose a target corpus, closing timetable, investment mandate detail or deployment target, so the future contribution of IYP III to fee-paying AUM cannot be quantified from the presentation.
The reported fundraising and deployment measures cover different periods and scopes. More than $208 crore of fundraising applies to the six months of H1FY27 and spans several strategies, whereas $14.5 crore of deployment is a Q2FY27 figure. The figures therefore cannot establish a quarterly fundraising-to-deployment ratio.
Got a follow-up? Ask IRIS
How did Edelweiss Alternatives' quarterly profit change?
Edelweiss Alternatives reported Q2FY27 PAT of $9 crore, compared with $7 crore in Q2FY26, and stated that quarterly PAT rose 27% year on year. Total income increased by $30 lakh to $2.9 crore, while operating expenses, or opex, increased by $10 lakh to $1.8 crore.
The disclosed income increase of $30 lakh was accompanied by a $10 lakh rise in opex between Q2FY26 and Q2FY27. This arithmetic comparison shows the movement in reported lines, but the presentation does not provide a revenue mix, staff-cost breakdown, fund-level margin or explanation for the cost increase.
PAT increased by $2 crore while fee-paying AUM rose by $110.5 crore over the same year-on-year comparison. The source does not disclose adjusted PAT, exceptional items or a breakdown of management fees, performance-related income and other revenue, so it does not quantify the mechanisms behind the reported profit growth.
What changed in Edelweiss Alternatives' return on equity?
Edelweiss Alternatives reported annualized RoE of 29% in Q2FY27, compared with 27% in Q2FY26. Management described the improvement as about 270 basis points, where one basis point equals one-hundredth of a percentage point, while the financial snapshot shows the rounded 29% and 27% figures.
The higher annualized RoE was reported with equity of $12.7 crore at September 2026, up from $10.7 crore at September 2025, and quarterly PAT of $9 crore, compared with $7 crore. The presentation does not specify whether its annualized RoE calculation uses average equity, closing equity or another method, so the 29% is the company-reported measure.
Fee-paying AUM and equity are separate measures in the presentation. Fee-paying AUM was $512.2 crore in Q2FY27, while equity was $12.7 crore at September; the former represents assets on which the business earns fees, while the latter is listed with financial performance and RoE metrics.
The reported annualized RoE movement coincided with higher AUM, income and PAT, but the source does not attribute the change to any one factor. It does not quantify the effects of fundraising, realisations of $38.8 crore, investment performance, product mix or operating costs on the 29% annualized RoE.
Conclusion
Edelweiss Alternatives combined a 28% year-on-year increase in fee-paying AUM to $512.2 crore with a stated 27% rise in Q2FY27 PAT to $9 crore. Income rose by $30 lakh to $2.9 crore and opex by $10 lakh to $1.8 crore, while annualized RoE was reported at 29%, compared with 27% a year earlier.
The next disclosed execution point is IYP III, the newly launched third-vintage infrastructure yield fund, together with more than $208 crore raised across named strategies and InvITs in H1FY27. Future reporting can show how these fundraising efforts, Q2FY27 deployment of $14.5 crore and realisation of $38.8 crore affect fee-paying AUM and earnings.


